Physitrack PLC (PTRK.ST)
SEK 12.0
(-6.98%)
SEK 12.0
(-6.98%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.57 Million EUR | 330.25% |
| 2022 | 831.66 Thousand EUR | 0.0% |
| 2021 | - EUR | -100.0% |
| 2020 | 634.28 Thousand EUR | 0.0% |
| 2019 | - EUR | 0.0% |
| 2018 | - EUR | 0.0% |
| 2017 | - EUR | 0.0% |
| 2016 | - EUR | 0.0% |
| 2015 | - EUR | 0.0% |
| 2014 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 4.33 Million EUR | 18.79% |
| 2024 Q1 | 3.64 Million EUR | 1.87% |
| 2023 Q3 | 3.78 Million EUR | 2.52% |
| 2023 FY | 3.57 Million EUR | 330.25% |
| 2023 Q1 | 3.01 Million EUR | 262.93% |
| 2023 Q4 | 3.57 Million EUR | -5.52% |
| 2023 Q2 | 3.69 Million EUR | 22.38% |
| 2022 Q3 | 822.63 Thousand EUR | 0.0% |
| 2022 Q1 | - EUR | 0.0% |
| 2022 FY | 831.66 Thousand EUR | 0.0% |
| 2022 Q4 | 831.66 Thousand EUR | 1.1% |
| 2022 Q2 | - EUR | 0.0% |
| 2021 Q1 | 454.2 Thousand EUR | -28.39% |
| 2021 FY | - EUR | -100.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2021 Q4 | - EUR | 0.0% |
| 2021 Q2 | 100.4 Thousand EUR | -77.89% |
| 2020 Q1 | - EUR | 0.0% |
| 2020 FY | 634.28 Thousand EUR | 0.0% |
| 2020 Q4 | 634.28 Thousand EUR | 0.0% |
| 2019 FY | - EUR | 0.0% |
| 2018 FY | - EUR | 0.0% |
| 2017 FY | - EUR | 0.0% |
| 2016 FY | - EUR | 0.0% |
| 2015 FY | - EUR | 0.0% |
| 2014 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aino Health AB (publ) | 164 Thousand SEK | -2081.84% |
| Bonzun AB (publ) | 554 Thousand SEK | -545.888% |
| Kontigo Care AB (publ) | 3.67 Million SEK | 2.634% |
| Medhelp Care Aktiebolag (publ) | - SEK | -Infinity% |
| RaySearch Laboratories AB (publ) | 431.97 Million SEK | 99.172% |
| Surgical Science Sweden AB (publ) | 40.02 Million SEK | 91.06% |